Healthy Ideas, Healthy Returns is a growing platform that unites all major biomedical research organizations in the Benelux (28 institutions). HIHR events are attended by all major early stage Venture Capital funds in the Human Health in the Benelux region and the initiative is supported by J&J Innovation, INKEF Capital, Arnold&Siedsma and our supporting companies.

HIHR-1 HIHR-2 HIHR-3 HIHR-4 HIHR-5 HIHR-6* HIHR-7* HIHR-8*
* on line edition 2016 2017 2018 2019-5 2019-11 2020-6 2020-11 2021-5
pitch presentations 8 14 11 12 12 9 9 7
quickfire sessions 10 9 4 12
investors / corporates 14 23 27 43 37 46 44 37
affiliated PROs 10 16 16 22 28 28 28 28

 

Participating institutions

The Netherlands: Universities and Academic Hospitals of Leiden, Utrecht, Groningen, Nijmegen, Amsterdam (VU & UvA); Technical Universities of Twente and Eindhoven; Erasmus Medical Centre Rotterdam; Wageningen University&Research; Netherlands Cancer Institute, Oncode Institute and the Royal Netherlands Academy of Arts and Sciences, representing ten research institutions.

Belgium: Universities and Academic Hospitals of Antwerp, Free University of Brussels, Ghent, Hasselt, Leuven, Liege, Mons, Namur & the Université Catholique de Louvain, Université Libre de Bruxelles; Flemish Institute for Biotechnology (VIB) & IMEC.

Luxembourg: Luxembourg Institute of Health, University of Luxembourg.

Participating funds / companies

Aglaia Oncology Funds, Bayer AG, Biogeneration Ventures, Bioqube Ventures, BOM Brabant Ventures, Brightlands Venture Partners BV, Cascara Ventures Bvba, CD3 – Centre for Drug Design and Discovery, Curie Capital, flanders.bio, Fondation Fournier-Majoie, Forbion, Fundplus, Galapagos, Gilde Healthcare, Gimv, HEBE, Het Fonds’, imec.xpand Fund, Inkef Capital, Janssen Pharmaceutica NV, JLABS EMEA, Johnson & Johnson Innovation/ JLABS, KBC Securities, Kurma Partners, LC Patents, LRM, LSP, Lunghealth, Nextgen Ventures, NLC Ventures, Noshaq, Novalis Biotech Accelerator, Novuqare Pelvic Health BV, Oncode Bridge fund, PMV, Pharma Connect Capital, Qbic II, Sopartec, Swanbridge Capital, Theodorus, Thuja Capital management, Tuspark Capital Management Luxembourg) SARL, UCB Ventures, UCB Biopharma, UNIIQ, Utrecht Health Seed Fund, V-Bio Ventures, Vives

Spin Off companies / projects presented via HIHR

Download here the list of Spin offs / projects that have presented themselves via HIHR since 2016.

Syllabi of past HIHR editions

We look forward to meeting you at one of our events!

Participating academic institutions in the Benelux, incl their UMC's

Radboud umc
Wageningen University & Research

Preferred partner

Silver partners

LC Patents - Arnold & Siedsma